Estrella's Sizzling Hot Stock Plays

Home Buying: More Costs Than Meets the Eye Let's face it, buying a home is no stroll in the park. It's a tangled web of numbers and surprises that can leave even the savviest buyer in a daze. Thank goodness for articles like the one from HelloNation featuring Serena LoPiccolo-Smith, which make the invisible visible when it comes to the financial intricacies of home...

The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Safe Bulkers (NYSE:SB) is gearing up to release its quarterly earnings on February 18, 2026, and the desks are buzzing about what this could mean for traders. Analysts are estimating an earnings per share (EPS) of $0.17—up from previous figures but under scrutiny given the current market landscape. What’s Cooking? Earnings Expectations So here's the scoop: a $0.17 EPS...

Goldman Sachs Adjusts Dover Corp's Price Target Recently, Goldman Sachs made a noteworthy adjustment to the price target of Dover Corp (NYSE:DOV), nudging it up to $202 from the previously set target of $201. The firm has maintained a Buy rating on the stock, reflecting confidence in its potential for growth and profitability. Positive Financial Outlook for Dover...

Myriad Venture Partners Welcomes New Leadership Myriad Venture Partners, a progressive firm focused on early-stage investments, is taking strategic steps to enhance its operational capabilities. The firm has recently appointed Sarah Adams as Partner and Head of Platform. This appointment is a significant move towards optimizing its investment strategies and expanding the...

Liquid Biopsy Market Overview and Growth Drivers The global liquid biopsy market is set for significant expansion, with a valuation of US$3.65 billion in 2024 and expectations to reach US$7.05 billion by 2030. This rapid growth is fueled by the increasing incidence of cancer and the expanding use of precision medicine. This innovative diagnostic method allows clinicians...

MaxCyte Director's Recent Share Activity Explained MaxCyte Inc. (NASDAQ: MXCT; LSE: MXCT), a pioneering entity in cell-engineering technologies tailored for cell therapeutics and research, has seen notable activity from its Non-Executive Director, John Johnston. Recently, Johnston exercised options over 3,000 shares of common stock, capitalizing on market opportunities....